Status:
COMPLETED
Acute Effects of Supplemental Oxygen on Memory Testing in Healthy Adult Volunteers
Lead Sponsor:
Inogen Inc.
Conditions:
Cognition
Eligibility:
All Genders
22-80 years
Phase:
NA
Brief Summary
Forty healthy adults (i.e., not recruited with respect to any particular diagnosis) are each alternately provided with supplemental oxygen and air via nasal cannula at about 6 Liters per Minute (LPM),...
Detailed Description
Prior studies have reported that supplemental oxygen can confer acute benefits to cognition. Here, the investigators seek to replicate/extend such findings by assessing whether such benefits can be se...
Eligibility Criteria
Inclusion
- Subjects are intended to represent "healthy adults." Patients will include a mix of self-reported gender and ethnic/racial identification.
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Adult (aged 22+)
Exclusion
- Patients who self-report diagnosis of respiratory-related conditions will be excluded.
- Subjects with a known polyvinyl chloride (PVC) allergy will be excluded, due to potential use of a standard, PVC-based cannula in the study.
Key Trial Info
Start Date :
May 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06555484
Start Date
May 28 2024
End Date
October 31 2024
Last Update
January 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Two Liberty Place
Philadelphia, Pennsylvania, United States, 19102